Team:Tsinghua
From 2014.igem.org
(Difference between revisions)
(28 intermediate revisions not shown) | |||
Line 3: | Line 3: | ||
{{Team:Tsinghua/css/jquery-1.10.1.min.js}} | {{Team:Tsinghua/css/jquery-1.10.1.min.js}} | ||
<html> | <html> | ||
- | < | + | <body onload=' location.href="#anchor1" '> |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
<div class="container"> | <div class="container"> | ||
<div id="sheet1"> | <div id="sheet1"> | ||
+ | <a id='anchor1' href='#'></a> | ||
<div class="contentbox"> | <div class="contentbox"> | ||
<span> | <span> | ||
<div id="image1" class="floating"> | <div id="image1" class="floating"> | ||
- | <img src="../ | + | <img src="https://static.igem.org/mediawiki/2014/6/63/Tsinghua_Emoji-4.png" width="200" height="250" alt=""/> |
</div> | </div> | ||
<div id="text1" class="slideLeft"> | <div id="text1" class="slideLeft"> | ||
- | <h1>Hi | + | <h1 class="customtext">Hi! We are <font color="990099">Team Tsinghua</font>. We present to you a <font color="990099">gene therapy</font> for Type 1 Diabetes Mellitus (T1DM).</h1> |
</div> | </div> | ||
</span> | </span> | ||
</div> | </div> | ||
<div class="arrow"> | <div class="arrow"> | ||
- | <img src=" | + | <img src="https://static.igem.org/mediawiki/2014/f/f2/Tsinghua_arrow.png" width="22" height="27" alt=""/> |
<p>Scroll down</p> | <p>Scroll down</p> | ||
</div> | </div> | ||
Line 34: | Line 26: | ||
<span> | <span> | ||
<div id="image2" class="tossing"> | <div id="image2" class="tossing"> | ||
- | <img src="../ | + | <img src="https://static.igem.org/mediawiki/2014/2/23/Tsinghua_Emoji-2.png" width="200" height="250" alt=""/> |
</div> | </div> | ||
<div id="text2"> | <div id="text2"> | ||
- | <h1 | + | <h1 class="customtext"><font color="990099">T1DM</font> results from autoimmune destruction of pancreatic beta cells. Our approach converts somatic cells into regulated insulin-producing cells, thus eliminating the need for continuous insulin therapy.</h1> |
</div> | </div> | ||
</span> | </span> | ||
</div> | </div> | ||
<div class="arrow"> | <div class="arrow"> | ||
- | <img src=" | + | <img src="https://static.igem.org/mediawiki/2014/f/f2/Tsinghua_arrow.png" width="22" height="27" alt=""/> |
<p>Scroll down</p> | <p>Scroll down</p> | ||
</div> | </div> | ||
Line 50: | Line 42: | ||
<span> | <span> | ||
<div id="image3"> | <div id="image3"> | ||
- | <img src="../ | + | <img src="https://static.igem.org/mediawiki/2014/4/4a/Tsinghua_Logo300x409.png" width="150" height="204.5" alt=""/> |
</div> | </div> | ||
<div id="text3"> | <div id="text3"> | ||
- | <h1>We use <font color="990099">Adeno-associated | + | <h1 class="customtext">We use <font color="990099">Adeno-associated virus (AAV)</font> as a transfection vector to introduce genes, which has proven to be safe… Well, that’s a whole other story, want to know more? </h1> |
</div> | </div> | ||
</span> | </span> | ||
</div> | </div> | ||
<div class="arrow"> | <div class="arrow"> | ||
- | <img src=" | + | <img src="https://static.igem.org/mediawiki/2014/f/f2/Tsinghua_arrow.png" width="22" height="27" alt=""/> |
<p>Scroll down</p> | <p>Scroll down</p> | ||
</div> | </div> | ||
</div> | </div> | ||
<div id="sheet4"> | <div id="sheet4"> | ||
- | <a href=" | + | <a href="https://2014.igem.org/Team:Tsinghua/Main_page">Get Started!</a> |
</div> | </div> | ||
</div> | </div> | ||
Line 72: | Line 64: | ||
var topOfWindow = $(window).scrollTop(); | var topOfWindow = $(window).scrollTop(); | ||
- | if (imagePos < topOfWindow+ | + | if (imagePos < topOfWindow+400) { |
- | $(this).addClass(" | + | $(this).addClass("expandUp"); |
} | } | ||
}); | }); |
Latest revision as of 18:20, 15 October 2014
T1DM results from autoimmune destruction of pancreatic beta cells. Our approach converts somatic cells into regulated insulin-producing cells, thus eliminating the need for continuous insulin therapy.
Scroll down
We use Adeno-associated virus (AAV) as a transfection vector to introduce genes, which has proven to be safe… Well, that’s a whole other story, want to know more?
Scroll down